Histamine‐2 Receptor Blockers Alter the Fecal Microbiota in Premature Infants
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Objectives: Bacterial colonization is considered a major risk factor for necrotizing enterocolitis (NEC). The objective of the present study was to test the hypothesis that histamine‐2 receptor (H2‐) blockers alter colonic bacterial colonization by analyzing and comparing the fecal microbiota in premature infants with and without H2‐blocker therapy using sensitive molecular biological techniques. Methods: Seventy‐six premature infants ≤1500 g or <34 weeks gestation were enrolled in this case‐controlled, cross‐sectional study. Stool samples were collected from 25 infants receiving H2‐blockers and 51 babies who had never received them. Following DNA extraction and PCR amplification of 16S rRNA, 454 pyrosequencing was undertaken and the resulting sequences were subjected to comparison with published sequence libraries. Results: Proteobacteria and Firmicutes were the major phyla contributing to fecal microbial communities. Microbial diversity was lower, relative abundance of Proteobacteria (primarily of the family Enterobacteriaceae) was increased, whereas that of Firmicutes was decreased in the stools of infants receiving H2‐blockers compared with those who had never received them. Conclusions: Although not designed to look specifically at the effect of H2‐blockers on the incidence of NEC, our study suggests that their use lowers fecal microbial diversity and shifts the microfloral pattern toward Proteobacteria. These alterations in fecal microbiota may predispose the vulnerable immature gut to necrotizing enterocolitis and suggest prudence in the use of H2‐blockers in the premature infant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development of the Human Infant Intestinal Microbiota
Palmer, C., Bik, E. M., DiGiulio, D. B., Relman, D. A., & Brown, P. O. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050177 · Cited by 2,877 · cited 2×
“The predominant bacterial phyla found in the GI tract are Firmicutes, Bacteroidetes, and Proteobacteria (4).”
BackgroundNeu, J., & Walker, W. A. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1005408 · Cited by 2,141
Cited by
The Human Neonatal Gut Microbiome: A Brief Review
Gritz, E. C., & Bhandari, V. (2015) · Frontiers in Pediatrics · doi:10.3389/fped.2015.00017 · Cited by 305
He, B., Hoang, T. K., Wang, T., Ferris, M., Taylor, C. M., Tian, X., Luo, M., Tran, D. Q., Zhou, J., Tatevian, N., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20160961 · Cited by 196
“Clinical management has not been updated since 1993 (Hannibal and Torgerson, 2011).”
BackgroundSelf-citationHospitalization type and subsequent severe sepsis
Prescott, H. C., Dickson, R. P., Rogers, M. A. M., Langa, K. M., & Iwashyna, T. J. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201503-0483oc · Cited by 181
“, minor infections not requiring hospitalization and common medications known to influence the microbiome [antibiotics, proton pump inhibitors (57), H2 receptor antagonists (58), and antidepressants (59)]) influence patients’ risk for developing severe sepsis, and whether these risks depend on the dosage and duration…”
BackgroundGao, C., Major, A., Rendon, D., Lugo, M., Jackson, V., Shi, Z., Mori-Akiyama, Y., & Versalovic, J. (2015) · mBio · doi:10.1128/mbio.01358-15 · Cited by 176
Antibiotic and acid-suppression medications during early childhood are associated with obesity
Stark, C. M., Susi, A., Emerick, J., & Nylund, C. M. (2019) · Gut · doi:10.1136/gutjnl-2017-314971 · Cited by 115
Metadata
- Authors
- Gupta, R. W., Tran, L., Norori, J., Ferris, M. J., Eren, A. M., Taylor, C. M., Dowd, S. E., & Penn, D.
- Venue
- Journal of Pediatric Gastroenterology and Nutrition
- Publisher
- Wiley
- Published
- 2013-04
- Volume
- 56
- Issue
- 4
- Pages
- 397-400
- ISSN
- 0277-2116 (ISSN-L)
- 1536-4801
- OpenAlex
- W2051744507
- Cited by
- 106
- References
- 2
- FWCI
- 4.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.